Fasted morning resistance exercise for Type 1 Diabetes

Alberta Diabetes Institute, Edmonton, Canada
Type 1 DiabetesFasted morning resistance exercise - Behavioral
18 - 55
All Sexes

Study Summary

This trial will study how blood sugar responds to exercise at different times of day in people with type 1 diabetes.

Eligible Conditions
  • Type 1 Diabetes

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Similar Trials

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: 0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes

0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes
Capillary glucose (change during exercise)
Hour 24
CGM coefficient of variation (CV)
CGM standard deviation (SD)
Mean CGM glucose
frequency of hyperglycemia
frequency of hypoglycemia
percent time in hyperglycemia
percent time in hypoglycemia
percent time in range
6 hrs, 12 hrs, overnight (midnight to 6am) and 24 hrs post-exercise
% time in hyperglycemia
% time in hypoglycemia
% time in range

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

All participants
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Fasted morning resistance exercise · No Placebo Group · N/A

All participantsExperimental Group · 2 Interventions: Afternoon resistance exercise, Fasted morning resistance exercise · Intervention Types: Behavioral, Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes

Who is running the clinical trial?

DexCom, Inc.Industry Sponsor
129 Previous Clinical Trials
29,503 Total Patients Enrolled
University of AlbertaLead Sponsor
842 Previous Clinical Trials
387,075 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Can individuals aged 60 or older enroll in this research study?

"This trial has a strict age range, with eligible participants being 18 years old or older and no older than 55." - Anonymous Online Contributor

Unverified Answer

Who has the opportunity to participate in this research endeavor?

"A diabetes diagnosis and a diagnosis of an autoimmune disorder are the two primary criteria for admission into this trial. Patients must also be between 18 and 55 years old in order to qualify, with approximately 15 slots available overall." - Anonymous Online Contributor

Unverified Answer

Is this research initiative accepting new participants?

"Based on the details present at, this medical experiment is actively seeking volunteers. It was uploaded to the website on November 16th 2021 and most recently revised January 10th 2022." - Anonymous Online Contributor

Unverified Answer

How many participants are there in this experiment?

"Affirmative. Accessible on the website, this medical trial was first posted on 16th November 2021 and is still actively recruiting participants. The study requires 15 test subjects from a single experimental site for evaluation purposes." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.